Romaciclib

N/A

Report date: 2025/12/29 17:55:00
NME

Base Information

Drug NameRomaciclib
Drug Alias NameSEL-120SEL120-34SEL120-34ARVU-120
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 8 inhibitorsCyclin-dependent kinase 19 inhibitors
TargetsCyclin-dependent kinase 8Cyclin-dependent kinase 19
Therapy Area/IndicationsSolid tumoursPrimary MyelofibrosisMyelodysplastic Syndromes +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRyvu Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesRyvu Therapeutics SaGCP-Service International West GmbH
Inactive CompaniesN/A
Active IndicationsSolid tumoursPrimary MyelofibrosisMyelodysplastic Syndromes +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A